Evidence map›Paper›PMID 37877875›Full record

ArticleUrology research & practice2023

The Prime Time for Flexible Ureteroscopy for Large Renal Stones Is Coming: Is Percutaneous Nephrolithotomy No Longer Needed?

Senol Tonyali, Hakan Bahadir Haberal, Francesco Esperto, Zeeshan Hamid, Lazaros Tzelves, Amelia Pietropaolo, Esteban Emiliani

Open access · diamondAbstract read
In one paragraph

Article in Urology research & practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Senol TonyaliDepartment of Urology, Istanbul University Istanbul School of Medicine, Istanbul, Turkey; European Association of Urology, Young Academic Urologist, Urolithiasis and Endourology Working Group, Arnhem, Netherlands.
Hakan Bahadir HaberalDepartment of Urology, University of Health Sciences, Ankara Sanatorium Training and Research hospital, Ankara, Turkey.
Francesco EspertoEuropean Association of Urology, Young Academic Urologist, Urolithiasis and Endourology Working Group, Arnhem, Netherlands; Department of Urology, Campus Bio-Medico, University of Rome, Rome, Italy.
Zeeshan HamidEuropean Association of Urology, Young Academic Urologist, Urolithiasis and Endourology Working Group, Arnhem, Netherlands; Department of Urology, Father Muller Medical College, Mangalore, India.
Lazaros TzelvesEuropean Association of Urology, Young Academic Urologist, Urolithiasis and Endourology Working Group, Arnhem, Netherlands; Department of Urology/Urooncology, University College of London Hospitals (UCLH), London, United Kingdom.
Amelia PietropaoloEuropean Association of Urology, Young Academic Urologist, Urolithiasis and Endourology Working Group, Arnhem, Netherlands; Department of Urology, University Hospital Southampton NHS Trust, Southampton, United Kingdom.
Esteban EmilianiEuropean Association of Urology, Young Academic Urologist, Urolithiasis and Endourology Working Group, Arnhem, Netherlands.
European Association of Urology · NLMinistry of Health · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in laser technology and surgical telescopic systems have propelled retrograde intrarenal surgery (RIRS) to the forefront as a viable alternative to percutaneous nephrolithotomy (PCNL). Currently, RIRS is being increasingly utilized as a treatment option, even for kidney stones larger than 2 cm. In this narrative review, we aimed to take a snapshot of current practice in renal stone treatment and the latest technological and technical developments and to evaluate the efficacy of RIRS in larger renal stones. With low complication rates and acceptable stone-free rates, RIRS offers patients a less invasive option with favorable outcomes. There are insufficient data comparing PCNL with RIRS using a new-generation high-power laser and suctioning ureteral access sheath (UAS). Further studies with novel lasers and UAS could provide superiority in terms of RIRS. It is crucial to take into account various patient-specific considerations, such as stone location and burden, when deciding on the appropriate treatment approach.

Identifiers

PMID37877875
PMCPMC10646796
OpenAlexW4387265460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.